NGB, Corp
NGB, Corp appears in FDA public data with 1 recall — including 1 Class I (most serious) —, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (F-1134-2018, Class I) was initiated on March 16, 2018.
Summary
- Total Recalls
- 1 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| F-1134-2018 | Class I | Nxtgen Botanicals, Maeng Da Kratom, Dietary Supplement, 70 capsules | March 16, 2018 |